LFCR vs PDD · $207.1M cap vs P/E 8.4, rev $61.75B
Lifecore Biomedical Inc. (LFCR) versus PDD Holdings Inc. (PDD) — a side-by-side from cached financials, not a winner call.
Lifecore Biomedical Inc. (LFCR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
PDD Holdings Inc. (PDD) is a internet retail company listed on NASDAQ.
LFCR does not have a complete income-statement cache yet.
Latest reported PDD revenue for 2025-12-31 was $61.75B. Net income was $13.99B. Revenue was up 14.5% from 2024-12-31 to 2025-12-31. PDD currently screens at market cap $113.67B and trailing P/E 8.4.
LFCR currently screens at market cap $207.1M. PDD currently screens at market cap $113.67B and trailing P/E 8.4.
Not investment advice. Open the LFCR and PDD stock pages for the full models.
Not investment advice.